Advertisement

Topics

DeuteRx to Present at the 2nd Annual H.C. Wainwright NASH Investor Conference

08:00 EDT 14 Mar 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Presentation to be webcast on March 19 at 5:20 p.m. ET DeuteRx LLC, a clinical stage biopharmaceutical company dedicated to improving racemic drugs, today announced that its President and Chief Executive Officer, Shei...

Other Sources for this Article

Media
MacDougall Biomedical Communications
Douglas MacDougall or Amanda Houlihan
781-235-3060
ahoulihan@macbiocom.com

NEXT ARTICLE

More From BioPortfolio on "DeuteRx to Present at the 2nd Annual H.C. Wainwright NASH Investor Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...